Shingrix vaccine gets FDA nod for the prevention of shingles
by Press Release from Outbreak News Today on (#35NTZ)
One week after Canadian officials approved GlaxoSmithKline's shingles vaccine, Shingrix, the US Food and Drug Administration (FDA) gave the vaccine it's approval. The FDA on Friday approved Shingrix (Zoster Vaccine Recombinant, Adjuvanted) for the prevention of shingles (herpes zoster) in adults aged 50 years and older. Shingrix is a non-live, recombinant subunit vaccine given intramuscularly in two ["]
The post Shingrix vaccine gets FDA nod for the prevention of shingles appeared first on Outbreak News Today.